Systemic inflammation Since NF-B sits at the center of inflammation throughout the body, KPV's ability to dampen it is studied beyond the gut and skin
Apart from improving blood sugar in type 2 diabetes and promoting significant weight loss, Ozempic is also FDA-approved for reducing the risk of heart diseases, worsening kidney disease, end-stage kidney disease, and death in patients with chronic kidney disease and type 2 diabetes
Its research scope has expanded from cardiovascular diseases to other systemic diseases, including pulmonary, kidney, neurological, and pancreatic diseases
( Epub 2011 Nov 1 PMID: 22092662 ) Funding No funding was received for the study
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells